Alaunos Therapeutics, Inc.

TCRTCIK 0001107421 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0019

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 26, 20268.01 · Other Events9.01 · Financial Statements and Exhibits May 18, 2026no items parsed Apr 15, 2026no items parsed Mar 2, 2026no items parsed Jan 8, 2026no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Alaunos Therapeutics, Inc.

Name	Roles	Filings
Postma Robert W	Director	10
Vieser Jaime	Director	10
Weis Holger	OfficerDirector	7
Jerman Michael Allen	Director	4
Boyle Kevin S. Sr.	OfficerDirector	3

Showing 1-5 of 16

Per pagePage 1 of 4Next

All filings

57 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jan 15, 2026	Postma Robert W Director	AGrant	5,622	$2.89	$16,248
Jan 15, 2026	Jerman Michael Allen Director	AGrant	5,406	$2.89	$15,623
Nov 26, 2025	Jerman Michael Allen Director	AGrant	4,183	$3.16	$13,218
Nov 26, 2025	Postma Robert W Director	AGrant	5,142	$3.16	$16,249
Nov 26, 2025	Vieser Jaime Director	AGrant	5,340	$3.16	$16,874

Showing 6-10 of 57

Per pagePrevPage 2 of 12Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value